Literature DB >> 24584456

Impact of pericardium bovine patch (Tutomesh(®)) on incisional hernia treatment in contaminated or potentially contaminated fields: retrospective comparative study.

A Gurrado1, I F Franco, G Lissidini, G Greco, M De Fazio, A Pasculli, A Girardi, G Piccinni, V Memeo, M Testini.   

Abstract

PURPOSE: This retrospective comparative study analyzes the outcome of patients affected by incisional hernia in potentially contaminated or contaminated field, treated by three operative techniques.
METHODS: 152 patients (62 M:90 F; mean age 65 ± 14 years) underwent incisional hernia repair (January 2002-January 2012) in complicated settings. Criteria of inclusion in the study were represented by the following causes of admission: mesh rejection/infection, obstruction without gangrene but with possible peritoneal bacterial translocation, obstruction with gangrene, enterocutaneous fistula or simultaneous presence of ileo- or colostomy. The patients were divided into three groups: A (n = 76), treated with primary closure technique; B and C (n = 38 each), with reinforcement by synthetic or pericardium bovine mesh (Tutomesh(®)), respectively. The prosthetic groups were divided into Onlay and Sublay subgroups.
RESULTS: Significant decreases in C vs A were observed for wound infection (3 vs 37%) and recurrence (0 vs 14%), and in C vs B for wound infection (3 vs 53%), seroma (0 vs 34%) and recurrence (0 vs 16%). Patients with concomitant bowel resection (BR) (43%) showed (all P < 0.05) an increase of overall morbidity (55 vs 33%) and wound infection rate (42 vs 24%) compared to cases without BR. Morbidity presented no significant differences in C-Onlay or Sublay subgroups. B-Sublay subgroup has (all P < 0.05) lower overall morbidity (20 vs 75%), wound infection (10 vs 68%) and seroma (0 vs 46%) than B-Onlay.
CONCLUSIONS: The pericardium bovine patch seems to be safe and effective to successfully repair ventral hernia in potentially contaminated operative fields, especially in association with bowel resection.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24584456     DOI: 10.1007/s10029-014-1228-6

Source DB:  PubMed          Journal:  Hernia        ISSN: 1248-9204            Impact factor:   4.739


  27 in total

Review 1.  Surgical treatment of incisional hernia.

Authors:  K Cassar; A Munro
Journal:  Br J Surg       Date:  2002-05       Impact factor: 6.939

2.  Use of porcine dermal collagen graft (Permacol) for hernia repair in contaminated fields.

Authors:  F Catena; L Ansaloni; F Gazzotti; S Gagliardi; S Di Saverio; L D'Alessandro; A D Pinna
Journal:  Hernia       Date:  2006-11-21       Impact factor: 4.739

3.  Retrofascial mesh repair of ventral incisional hernias.

Authors:  Hamilton Le; Jeffrey S Bender
Journal:  Am J Surg       Date:  2005-03       Impact factor: 2.565

4.  One-year follow-up after incisional hernia treatment: results of a prospective randomized study.

Authors:  L Venclauskas; A Maleckas; M Kiudelis
Journal:  Hernia       Date:  2010-06-22       Impact factor: 4.739

5.  Modifications to Rives technique for midline incisional hernia repair.

Authors:  A Martín-Duce; F Noguerales; R Villeta; P Hernández; O Lozano; J Keller; J Granell
Journal:  Hernia       Date:  2001-06       Impact factor: 4.739

6.  Acellular extracellular matrix for inguinal hernia repair.

Authors:  S Z Ma; X H Li; J Hu
Journal:  Hernia       Date:  2006-01-27       Impact factor: 4.739

7.  Long-term follow-up of a randomized controlled trial of suture versus mesh repair of incisional hernia.

Authors:  Jacobus W A Burger; Roland W Luijendijk; Wim C J Hop; Jens A Halm; Emiel G G Verdaasdonk; Johannes Jeekel
Journal:  Ann Surg       Date:  2004-10       Impact factor: 12.969

8.  Use of bovine pericardium graft for abdominal wall reconstruction in contaminated fields.

Authors:  Luigi D'Ambra; Stefano Berti; Cosimo Feleppa; Prospero Magistrelli; Pierfrancesco Bonfante; Emilio Falco
Journal:  World J Gastrointest Surg       Date:  2012-07-27

9.  Bovine versus porcine acellular dermal matrix for complex abdominal wall reconstruction.

Authors:  Mark W Clemens; Jesse C Selber; Jun Liu; David M Adelman; Donald P Baumann; Patrick B Garvey; Charles E Butler
Journal:  Plast Reconstr Surg       Date:  2013-01       Impact factor: 4.730

10.  Repair of abdominal wall defects with bovine pericardium.

Authors:  Jonathan N Limpert; Ankit R Desai; Arthur L Kumpf; Michael A Fallucco; Della L Aridge
Journal:  Am J Surg       Date:  2009-10-06       Impact factor: 2.565

View more
  6 in total

1.  iBTA-induced bovine Biosheet for repair of abdominal wall defects in a beagle model: proof of concept.

Authors:  Y Nakayama; N Oshima; E Tatsumi; O Ichii; T Nishimura
Journal:  Hernia       Date:  2018-07-18       Impact factor: 4.739

Review 2.  Ventral hernia repair with synthetic mesh in a contaminated field: a systematic review and meta-analysis.

Authors:  M P Morris; J A Mellia; A N Christopher; M N Basta; V Patel; K Qiu; R B Broach; J P Fischer
Journal:  Hernia       Date:  2021-01-19       Impact factor: 4.739

Review 3.  The role of open abdomen in non-trauma patient: WSES Consensus Paper.

Authors:  Federico Coccolini; Giulia Montori; Marco Ceresoli; Fausto Catena; Ernest E Moore; Rao Ivatury; Walter Biffl; Andrew Peitzman; Raul Coimbra; Sandro Rizoli; Yoram Kluger; Fikri M Abu-Zidan; Massimo Sartelli; Marc De Moya; George Velmahos; Gustavo Pereira Fraga; Bruno M Pereira; Ari Leppaniemi; Marja A Boermeester; Andrew W Kirkpatrick; Ron Maier; Miklosh Bala; Boris Sakakushev; Vladimir Khokha; Manu Malbrain; Vanni Agnoletti; Ignacio Martin-Loeches; Michael Sugrue; Salomone Di Saverio; Ewen Griffiths; Kjetil Soreide; John E Mazuski; Addison K May; Philippe Montravers; Rita Maria Melotti; Michele Pisano; Francesco Salvetti; Gianmariano Marchesi; Tino M Valetti; Thomas Scalea; Osvaldo Chiara; Jeffry L Kashuk; Luca Ansaloni
Journal:  World J Emerg Surg       Date:  2017-08-14       Impact factor: 5.469

Review 4.  The open abdomen in trauma and non-trauma patients: WSES guidelines.

Authors:  Federico Coccolini; Derek Roberts; Luca Ansaloni; Rao Ivatury; Emiliano Gamberini; Yoram Kluger; Ernest E Moore; Raul Coimbra; Andrew W Kirkpatrick; Bruno M Pereira; Giulia Montori; Marco Ceresoli; Fikri M Abu-Zidan; Massimo Sartelli; George Velmahos; Gustavo Pereira Fraga; Ari Leppaniemi; Matti Tolonen; Joseph Galante; Tarek Razek; Ron Maier; Miklosh Bala; Boris Sakakushev; Vladimir Khokha; Manu Malbrain; Vanni Agnoletti; Andrew Peitzman; Zaza Demetrashvili; Michael Sugrue; Salomone Di Saverio; Ingo Martzi; Kjetil Soreide; Walter Biffl; Paula Ferrada; Neil Parry; Philippe Montravers; Rita Maria Melotti; Francesco Salvetti; Tino M Valetti; Thomas Scalea; Osvaldo Chiara; Stefania Cimbanassi; Jeffry L Kashuk; Martha Larrea; Juan Alberto Martinez Hernandez; Heng-Fu Lin; Mircea Chirica; Catherine Arvieux; Camilla Bing; Tal Horer; Belinda De Simone; Peter Masiakos; Viktor Reva; Nicola DeAngelis; Kaoru Kike; Zsolt J Balogh; Paola Fugazzola; Matteo Tomasoni; Rifat Latifi; Noel Naidoo; Dieter Weber; Lauri Handolin; Kenji Inaba; Andreas Hecker; Yuan Kuo-Ching; Carlos A Ordoñez; Sandro Rizoli; Carlos Augusto Gomes; Marc De Moya; Imtiaz Wani; Alain Chichom Mefire; Ken Boffard; Lena Napolitano; Fausto Catena
Journal:  World J Emerg Surg       Date:  2018-02-02       Impact factor: 5.469

5.  Effectiveness and safety of bovine pericardium patch repair for cervical anastomotic leakage after oesophagectomy for cancer.

Authors:  Xionghuai Hua; Rulin Qian; Kefeng Shi; Xiufeng Wei; Heng Zhang; Ge Qu; Maolin Chen; Binbin Zhang
Journal:  J Thorac Dis       Date:  2019-09       Impact factor: 2.895

Review 6.  What is the evidence for the use of biologic or biosynthetic meshes in abdominal wall reconstruction?

Authors:  F Köckerling; N N Alam; S A Antoniou; I R Daniels; F Famiglietti; R H Fortelny; M M Heiss; F Kallinowski; I Kyle-Leinhase; F Mayer; M Miserez; A Montgomery; S Morales-Conde; F Muysoms; S K Narang; A Petter-Puchner; W Reinpold; H Scheuerlein; M Smietanski; B Stechemesser; C Strey; G Woeste; N J Smart
Journal:  Hernia       Date:  2018-01-31       Impact factor: 4.739

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.